Welcome to LookChem.com Sign In|Join Free

CAS

  • or

15969-46-7

Post Buying Request

15969-46-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

15969-46-7 Usage

Structure

It is a heterocyclic organic compound and a derivative of pyrimidine.

Usage in pharmaceuticals and agrochemicals

It is commonly used as a starting material for the synthesis of various pharmaceuticals and agrochemicals.

Sedative and hypnotic properties

Barbituric acid is known for its sedative and hypnotic properties.

Historical use as a central nervous system depressant

It has been used in the past as a central nervous system depressant.

Decline in use

Its use has declined due to the development of safer and more effective alternatives.

Occasional use as a reagent

It is occasionally used as a reagent in organic chemical reactions.

Building block in synthesis

It serves as a building block in the synthesis of other organic compounds.

Stability

The compound is relatively stable and can be handled and stored safely under normal conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 15969-46-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,9,6 and 9 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 15969-46:
(7*1)+(6*5)+(5*9)+(4*6)+(3*9)+(2*4)+(1*6)=147
147 % 10 = 7
So 15969-46-7 is a valid CAS Registry Number.

15969-46-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-diphenyl-1H-pyrimidin-4-one

1.2 Other means of identification

Product number -
Other names 2,6-Diphenyl-3H-pyrimidin-4-on

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:15969-46-7 SDS

15969-46-7Relevant articles and documents

2,4,6-Trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists

Chang, Lisa C. W.,Spanjersberg, Ronald F.,Von Frijtag Drabbe Künzel, Jacobien K.,Mulder-Krieger, Thea,Van Den Hout, Gijs,Beukers, Margot W.,Brussee, Johannes,IJzerman, Adriaan P.

, p. 6529 - 6540 (2004)

Adenosine receptor antagonists usually possess a bi- or tricyclic heteroaromatic structure at their core with varying substitution patterns to achieve selectivity and/or greater affinity. Taking into account molecular modeling results from a series of pot

Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain

Lan, Yu,Chen, Yin,Cao, Xudong,Zhang, Juecheng,Wang, Jie,Xu, Xiangqing,Qiu, Yinli,Zhang, Tan,Liu, Xin,Liu, Bi-Feng,Zhang, Guisen

, p. 10404 - 10423 (2015/02/19)

The discovery and synthesis of a new series of pyrimidines as potent sigma-1 receptor (σ1R) antagonists, associated with pharmacological antineuropathic pain activity, are the focus of this article. The new compounds were evaluated in vitro in σ-1 and σ-2 receptor binding assays. The nature of the pyrimidine scaffold was crucial for activity, and a basic amine was shown to be necessary according to the known pharmacophoric model. The most promising derivative was 5-chloro-2-(4-chlorophenyl)-4-methyl-6-(3-(piperidin-1-yl)propoxy)pyrimidine (137), which exhibited a high binding affinity to σ1R receptor (Ki σ1 = 1.06 nM) and good σ-1/2 selectivity (1344-fold). In in vivo tests, compound 137 exerted dose-dependent antinociceptive effects in mice formalin model and rats CCI models of neuropathic pain. In addition, no motor impairments were found in rotarod tests; acceptable pharmacokinetic properties were also noted. These data suggest compound 137 may constitute a novel class of drugs for the treatment of neuropathic pain.

A metal-free tandem approach to prepare structurally diverse N-heterocycles: Synthesis of 1,2,4-oxadiazoles and pyrimidinones

Gupta, Puneet K.,Hussain, Mohd. Kamil,Asad, Mohd.,Kant, Ruchir,Mahar, Rohit,Shukla, Sanjeev K.,Hajela, Kanchan

, p. 3062 - 3070 (2014/07/07)

A metal-free one-pot approach to the diversity oriented synthesis of N-heterocycles, 1,2,4-oxadiazoles and 2,6 disubstituted pyrimidin-4-ones is described via carboxamidation of amidines with aryl carboxylic acids and aryl propargylic acids. The reactions occur at room temperature forming N-acylamidines which undergo tandem nucleophilic addition-deamination- intramolecular cyclisation to give the corresponding heterocyclic compounds in good to excellent yields. This one pot approach has led to the successful synthesis of the drug lead molecule, ataluren, 3-(5-(2-fluorophenyl)-1,2,4- oxadiazol-3-yl) benzoic acid in two steps. the Partner Organisations 2014.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 15969-46-7